Lo Andrew
SEC CIK 1679076 · EDGAR
BoughtSold
Most active insiders at BBIO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Kumar Neil | CEO, Dir | — | $61.54M |
| 2 | Cook Jennifer E. | Dir | — | $21.92M |
| 3 | MCCORMICK FRANK | Dir | — | $13.31M |
| 4 | Lo Andrew | Dir | — | $6.32M |
| 5 | Ellis Andrea | Dir | — | $5.65M |
| 6 | Valantine Hannah | Dir | — | $4.37M |
| 7 | DANIELS RONALD J | Dir | — | $3.89M |
| 8 | Trimarchi Thomas | Pres, CFO | — | $3.03M |
| 9 | Scott Randal W. | Dir | — | $2.09M |
| 10 | Apuli Maricel | CAO | — | $621.7K |
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-24 18:06 | 2026-06-22 | BBIO | BridgeBio Pharma, Inc. | Lo Andrew | Dir | A - Grant | $0.00 | +3,990 | 18.1K | +28% | $0 |
| M | 2025-11-19 | 2025-11-17 | BBIO | BridgeBio Pharma, Inc. | Lo Andrew | Dir | S - Sale | $66.67 | -40.6K | 14.1K | -74% | -$2.71M |
| MI | 2025-11-19 | 2025-11-18 | BBIO | BridgeBio Pharma, Inc. | Lo Andrew | Dir | S - Sale | $65.69 | -55.0K | 81.6K | -40% | -$3.61M |
| D | 2025-06-24 | 2025-06-20 | BBIO | BridgeBio Pharma, Inc. | Lo Andrew | Dir | A - Grant | $0.00 | +6,589 | 54.7K | +14% | $0 |
| I | 2025-05-06 | 2025-05-02 | BBIO | BridgeBio Pharma, Inc. | Lo Andrew | Dir | S - Sale | $38.50 | -100.0K | 105.6K | -49% | -$3.85M |
| D | 2022-09-19 | 2022-09-15 | ROIV | Roivant Sciences Ltd. | Lo Andrew | Dir | A - Grant | $0.00 | +52.1K | 52.1K | New | $0 |
| M | 2022-01-03 | 2021-12-29+ | BBIO | BridgeBio Pharma, Inc. | Lo Andrew | Dir | P - Purchase | $13.18 | +7,500 | 46.6K | +19% | +$98.8K |
| 2021-12-07 | 2021-12-03 | ABCL | AbCellera Biologics Inc. | Lo Andrew | Dir | P - Purchase | $14.02 | +86.9K | 86.9K | New | +$1.22M |
Purchase Sale Sale after option exercise All abbreviations